Featured News
AIM Blog
Investing in the Fight Against Alzheimer’s
Nearly 7 million Americans are currently living with Alzheimer’s — a number expected to rise to nearly 13 million by 2050 without medical breakthroughs. Thankfully, Congress has taken action over the ...
All News
Press Release
Alzheimer’s Association, Individuals Living with Alzheimer’s Urge FDA to Grant Traditional Approval for Lecanemab
CHICAGO, May 25, 2023 — The Alzheimer's Association and members of the Association's Early Stage Advisory Group submitted comments to...
Press Release
Alzheimer’s Advocate Testifies What Access to FDA-Approved Alzheimer’s Treatments Means
— Congressional Bipartisan Support for Individuals, Families and Treatment on Display — WASHINGTON, D.C., May 10, 2023 — Today, Tony...
Press Release
Alzheimer’s Association Statement on Donanemab Phase 3 Topline Data Release
Strongest Alzheimer's Phase 3 data release to date Association underscores urgent call for CMS to stop blocking access to FDA-approved...
AIM Blog
Recognizing AIM’s May Advocate of the Month: Priya Patel
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Overwhelming Bipartisan Support for Access to FDA-Approved Alzheimer’s Treatments on Display in Health Subcommittee Hearing
Bipartisan members sharply question CMS Administrator why Alzheimer’s drugs aren’t reasonable and necessary Washington, D.C., April 26, 2023 — Today...
AIM Blog
Sign the Petition: Urge President Biden to Tell CMS to Stop Blocking Access to Alzheimer’s Treatments
For over a year, the Centers for Medicare & Medicaid Services (CMS) has been blocking access to Food and Drug...